Northview Ventures

Northview LifeSciences operates as a specialized venture firm that actively creates, finances, and advances companies within the life sciences sector. The firm is adept at developing commercial strategies for therapeutics, medical devices, and diagnostic technologies, applying a hands-on approach to inform resource allocation and drive healthcare performance improvements. Its core capability lies in transforming scientific innovation into viable commercial enterprises.

Douglas Janzen co-founded Northview LifeSciences, with the firm establishing significant operations around 2015. The foundational insight stemmed from recognizing the critical need for strategic guidance and capital to effectively bring scientific breakthroughs to market within the intricate life sciences ecosystem. Janzen’s expertise guides the firm’s focus on nurturing and scaling emerging companies.

The firm's offerings are utilized by early-stage life science companies seeking both investment and strategic partnership to navigate product development and commercialization. Northview LifeSciences consistently integrates insights from end-users throughout its investment decisions. Its overarching vision is to continuously advance the business of science by fostering new companies that deliver impactful solutions to pressing healthcare challenges.